Covered recipient · General Payments record
THOMAS P PETRIE
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$1,592.63
- Reported across 85 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $451.19 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $198.62 | 19 |
| Biogen, Inc. | $119.05 | 3 |
| Tarsus Pharmaceuticals, Inc. | $47.26 | 2 |
| Astellas Pharma US Inc | $29.61 | 1 |
| Bausch & Lomb Americas Inc. | $23.03 | 1 |
| Pacira Pharmaceuticals Incorporated | $19.83 | 1 |
| Oyster Point Pharma, Inc. | $13.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.15 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251540 | CMS |
| ABBVIE INC. | $2.70 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251544 | CMS |
| ABBVIE INC. | $2.60 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251549 | CMS |
| ABBVIE INC. | $2.11 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251553 | CMS |
| ABBVIE INC. | $2.80 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251557 | CMS |
| ABBVIE INC. | $4.81 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251561 | CMS |
| ABBVIE INC. | $28.66 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251565 | CMS |
| ABBVIE INC. | $21.57 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251569 | CMS |
| ABBVIE INC. | $2.11 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251573 | CMS |
| ABBVIE INC. | $6.72 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251577 | CMS |
| ABBVIE INC. | $33.24 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251581 | CMS |
| ABBVIE INC. | $5.67 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251585 | CMS |
| ABBVIE INC. | $4.38 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251589 | CMS |
| ABBVIE INC. | $2.98 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251593 | CMS |
| ABBVIE INC. | $29.68 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251597 | CMS |
| ABBVIE INC. | $5.40 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251602 | CMS |
| ABBVIE INC. | $5.01 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251606 | CMS |
| ABBVIE INC. | $3.17 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251610 | CMS |
| ABBVIE INC. | $4.86 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251613 | CMS |
| Astellas Pharma US Inc | $29.61 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139439358 | CMS |
| Bausch & Lomb Americas Inc. | $23.03 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140459260 | CMS |
| Biogen, Inc. | $15.14 | 02/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104833507 | CMS |
| Biogen, Inc. | $13.81 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104835691 | CMS |
| Biogen, Inc. | $90.10 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104864848 | CMS |
| Oyster Point Pharma, Inc. | $13.79 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147420958 | CMS |
| Pacira Pharmaceuticals Incorporated | $19.83 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151260118 | CMS |
| Tarsus Pharmaceuticals, Inc. | $22.87 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139124468 | CMS |
| Tarsus Pharmaceuticals, Inc. | $24.39 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139124470 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.